{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:42:13Z","timestamp":1786984933409,"version":"build-2736575974"},"reference-count":113,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.autrev.2018.08.009","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T22:11:35Z","timestamp":1545084695000},"page":"155-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["An evolving redefinition of autoimmune encephalitis"],"prefix":"10.1016","volume":"18","author":[{"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.08.009_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/WCO.0000000000000199","article-title":"Epidemiology and outcomes of acute encephalitis","volume":"28","author":"Venkatesan","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1743-422X-5-134","article-title":"The incidence of acute encephalitis syndrome in Western industrialised and tropical countries","volume":"5","author":"Jmor","year":"2008","journal-title":"Virol J"},{"key":"10.1016\/j.autrev.2018.08.009_bb0015","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/B978-0-444-52910-7.00038-6","article-title":"Acute viral encephalitis","volume":"112","author":"Rozenberg","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0020","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2018.08.009_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuropharm.2017.04.046","article-title":"Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy","volume":"132","author":"Varley","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0035","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2018.08.009_bb0040","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/01.WNL.0000144340.03364.BF","article-title":"Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes","volume":"63","author":"Llad\u00f3","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/brain\/awv364","article-title":"'Moonlighting' surface antigens: a paradigm for autoantibody pathogenicity in neurology?","volume":"139","author":"Irani","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.08.009_bb0050","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/neuonc\/nou030","article-title":"Autoimmune encephalitis update","volume":"16","author":"Varley. Graus 2016, Dalmau J, Rosenfeld MR","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0055","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.autrev.2017.05.022","article-title":"Late-onset Rasmussen encephalitis: a literature appraisal","volume":"16","author":"Dupont","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.009_bb0060","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.autrev.2016.07.024","article-title":"Multiparametric serological testing in autoimmune encephalitis using computer-aided immunofluorescence microscopy (CAIFM)","volume":"15","author":"Fraune","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.009_bb0065","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.autrev.2016.07.018","article-title":"From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time","volume":"15","author":"van Sonderen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.009_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2017.07.012","article-title":"Neurobiology of autoimmune encephalitis","volume":"48","author":"Fukata","year":"2018","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.autrev.2018.01.011","article-title":"The role of ophthalmic imaging in central nervous system degeneration in systemic lupus erythematosus","volume":"17","author":"Dias-Santos","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.009_bb0080","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.autrev.2017.04.008","article-title":"The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface","volume":"16","author":"Stock","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.009_bb0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2016.12.002","article-title":"Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A\/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sj\u00f6gren's syndrome: an updated meta-analysis","volume":"16","author":"Tay","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.009_bb0090","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.autrev.2016.09.008","article-title":"Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature","volume":"15","author":"Laurent","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.009_bb0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.autrev.2016.01.014","article-title":"Hashimoto's encephalopathy: a rare proteiform disorder","volume":"15","author":"Montagna","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.009_bb0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.009_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117130","article-title":"Compartmentalization of GABA synthesis by GAD67 differs between pancreatic beta cells and neurons","volume":"10","author":"Kanaani","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.autrev.2018.08.009_bb0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jneuroim.2010.07.011","article-title":"GAD antibodies associated neurological disorders: incidence and phenotype distribution among neurological inflammatory diseases","volume":"227","author":"Mat\u00e0","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0120","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s00415-013-7110-0","article-title":"Anti-GAD antibody ocular flutter: expanding the spectrum of autoimmune ocular motor disorders","volume":"260","author":"Dubbioso","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants: classification, diagnosis and treatment","volume":"13","author":"T\u00fcz\u00fcn","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.autrev.2018.08.009_bb0130","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2015.05.017","article-title":"Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies","volume":"30","author":"Malter","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.autrev.2018.08.009_bb0140","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamaneurol.2016.0133","article-title":"Clinical and immunologic investigations in patients with Stiff-Person spectrum disorder","volume":"73","author":"Martinez-Hernandez","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2018.01.007","article-title":"Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: a comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus","volume":"317","author":"Nakajima","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0150","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ejpn.2018.01.004","article-title":"Severe dysautonomia as a main feature of anti-GAD encephalitis: Report of a paediatric case and literature review","volume":"22","author":"Ben Achour","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0155","doi-asserted-by":"crossref","first-page":"279298","DOI":"10.1016\/S0301-0082(99)00007-6","article-title":"Subunit- and site-specific pharmacology of the NMDA receptor channel","volume":"59","author":"Yamakura","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0160","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2018.08.009_bb0165","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/cne.903430402","article-title":"Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum","volume":"343","author":"Watanabe","year":"1994","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-328X(96)00117-9","article-title":"Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus","volume":"42","author":"Standaert","year":"1996","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.autrev.2018.08.009_bb0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1615\/CritRevNeurobiol.v18.i1-2.80","article-title":"Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors","volume":"18","author":"MacDonald","year":"2006","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0959-4388(00)00215-4","article-title":"NMDA receptor subunits: diversity, development and disease","volume":"11","author":"Cull-Candy","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0185","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","article-title":"Mice with reduced NMDA receptor expression display behaviors related to schizophrenia","volume":"98","author":"Mohn","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2018.08.009_bb0190","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1523\/JNEUROSCI.21-02-00750.2001","article-title":"Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor (1 subunit)","volume":"21","author":"Miyamoto","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2018.08.009_bb0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coph.2006.08.011","article-title":"NMDA receptor subunits: function and pharmacology","volume":"7","author":"Paoletti","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0200","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project","volume":"54","author":"Gable","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2018.08.009_bb0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0210","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/jnnp.2008.147611","article-title":"Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis","volume":"79","author":"Eker","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2018.08.009_bb0215","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cei.12185","article-title":"Paraneoplastic neurological syndromes","volume":"175","author":"Leypoldt","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0220","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0225","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2018.08.009_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yebeh.2016.12.019","article-title":"Clinical characteristics, treatments, and outcomes of patients with anti-N-methyl-D-aspartate receptor encephalitis: a systematic review of reported cases","volume":"68","author":"Zhang","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.autrev.2018.08.009_bb0235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0240","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jpeds.2012.10.011","article-title":"Spanish Anti-N-methyl-D-Aspartate Receptor (NMDAR) Encephalitis Work Group. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients","volume":"162","author":"Armangue","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2018.08.009_bb0245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pediatrneurol.2013.10.002","article-title":"Anti-N-methyl-D-aspartate receptor-mediated encephalitis in infants and toddlers: case report and review of the literature","volume":"50","author":"Goldberg","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0250","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis associated with acute Toxoplasma gondii infection: a case report","volume":"97","author":"Cai","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2018.08.009_bb0255","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1212\/WNL.0000000000003414","article-title":"NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: the 2016 Cotzias Lecture","volume":"87","author":"Dalmau","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0260","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/dmcn.13448","article-title":"Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases","volume":"59","author":"Nosadini","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0265","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/PCC.0b013e3181cf4652","article-title":"Neurological sequelae of 2009 influenza a (H1N1) in children: a case series observed during a pandemic","volume":"11","author":"Baltagi","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.autrev.2018.08.009_bb0270","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/MOP.0b013e3283402d2f","article-title":"Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents","volume":"22","author":"Florance-Ryan","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.autrev.2018.08.009_bb0275","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/mds.25354","article-title":"The spectrum of movement disorders in children with anti-NMDA receptor encephalitis","volume":"28","author":"Baizabal-Carvallo","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.autrev.2018.08.009_bb0280","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.clinph.2017.04.015","article-title":"Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China","volume":"128","author":"Zhang","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0285","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0290","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jocn.2018.03.026","article-title":"Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: a systematic review","volume":"52","author":"Bacchi","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.autrev.2018.08.009_bb0295","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamaneurol.2016.0232","article-title":"Association of Progressive Cerebellar Atrophy with Long-term Outcome in patients with Anti-N-Methyl\u2011d-Aspartate Receptor Encephalitis","volume":"73","author":"Iizuka","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0300","doi-asserted-by":"crossref","first-page":"e1997","DOI":"10.1212\/WNL.0000000000005605","article-title":"CHANCE Study Group. Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis","volume":"90","author":"de Bruijn","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0305","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","volume":"62","author":"Thieben","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0310","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1212\/01.wnl.0000326572.93762.51","article-title":"Immunotherapy-responsive seizure-like episodes with potassium channel antibodies","volume":"71","author":"Irani","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0315","doi-asserted-by":"crossref","unstructured":"Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, Schott JM, Armstrong RJ, S Zagami A, Bleasel A, Somerville ER, Smith SM, Vincent A. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;69:892\u2013900.","DOI":"10.1002\/ana.22307"},{"key":"10.1016\/j.autrev.2018.08.009_bb0320","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0325","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0330","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.08.009_bb0335","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0340","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp-2016-314758","article-title":"Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies","volume":"88","author":"Lang","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2018.08.009_bb0345","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2018.08.009_bb0350","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nm.3759","article-title":"Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy","volume":"21","author":"Yokoi","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2018.08.009_bb0355","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome","volume":"87","author":"Ari\u00f1o","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0360","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of Cognitive Deficits and Structural Hippocampal damage in Encephalitis with Leucine-Rich, Glioma-Inactivated 1 Antibodies","volume":"74","author":"Finke","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0365","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2017.05.017","article-title":"LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures","volume":"50","author":"Aurangzeb","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.autrev.2018.08.009_bb0370","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0375","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0380","doi-asserted-by":"crossref","first-page":"14213","DOI":"10.1523\/JNEUROSCI.3398-08.2008","article-title":"Multiple molecular interactions determine the clustering of Caspr2 and Kv1 channels in myelinated axons","volume":"28","author":"Horresh","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2018.08.009_bb0385","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1212\/NXI.0000000000000127","article-title":"Caspr2 autoantibodies target multiple epitopes","volume":"2","author":"Olsen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2018.08.009_bb0390","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0395","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0400","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000178","article-title":"Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease","volume":"2","author":"Maat","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2018.08.009_bb0405","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0410","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.08.009_bb0415","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0420","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/mp.2016.165","article-title":"Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice","volume":"21","author":"Brimberg","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.autrev.2018.08.009_bb0425","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","article-title":"Chronic pain as a manifestation of potassium channel-complex autoimmunity","volume":"79","author":"Klein","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0430","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.seizure.2013.06.004","article-title":"VGKC complex antibodies in epilepsy: diagnostic yield and therapeutic implications","volume":"22","author":"Lilleker","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.autrev.2018.08.009_bb0435","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/jnnp-2013-305252","article-title":"Neurological manifestations related to level of voltage-gated potassium channel antibodies","volume":"84","author":"Olberg","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2018.08.009_bb0440","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0000000000002637","article-title":"The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies","volume":"86","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0445","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/PRA.0000000000000265","article-title":"Voltage-gated potassium channel antibody autoimmune encephalopathy presenting with isolated psychosis in an adolescent","volume":"23","author":"Pon","year":"2017","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.autrev.2018.08.009_bb0450","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1152\/physrev.00043.2010","article-title":"Fast synaptic inhibition in spinal sensory processing and pain control","volume":"92","author":"Zeilhofer","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2018.08.009_bb0455","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/brain\/awt207","article-title":"Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay","volume":"136","author":"Thomas","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.08.009_bb0460","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00415-011-6377-2","article-title":"Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations","volume":"259","author":"Iizuka","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0465","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamaneurol.2016.0133","article-title":"Clinical and immunologic investigations in patients with Stiff-Person spectrum disorder","volume":"73","author":"Martinez-Hernandez","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0470","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.08.009_bb0475","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/dmcn.13090","article-title":"Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies","volume":"58","author":"Hacohen","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0480","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1212\/WNL.0b013e318247cd03","article-title":"GABAB receptors: structure, functions, and clinical implications","volume":"78","author":"Benarroch","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0485","doi-asserted-by":"crossref","unstructured":"Schuler V, Luscher C, Blanchet C, Klix C, Sansig G, Klebs K, Schmutz M, Heid J, Gentry C, Urban L, Fox A, Spooren W, Jaton AL, Vigouret J, Pozza M, Kelly PH, Mosbacher J, Froestl W, K\u00e4slin E, Korn R, Bischoff S, Kaupmann K, van der Putten H, Bettler B. Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron 2001;31:47\u201358.","DOI":"10.1016\/S0896-6273(01)00345-2"},{"key":"10.1016\/j.autrev.2018.08.009_bb0490","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eplepsyres.2011.04.014","article-title":"GABBR1 gene polymorphism(G1465A) is associated with temporal lobe epilepsy","volume":"96","author":"Xi","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.autrev.2018.08.009_bb0495","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.euroneuro.2004.12.006","article-title":"Possible association between the gamma-aminobutyric acid type B receptor 1 (GABBR1) gene and schizophrenia","volume":"15","author":"Zai","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0500","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ajmg.b.30152","article-title":"Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder","volume":"134B","author":"Zai","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.autrev.2018.08.009_bb0505","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0510","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0515","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.08.009_bb0520","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/jnnp-2014-308814","article-title":"Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series","volume":"86","author":"Dogan Onugoren","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2018.08.009_bb0525","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/00207454.2016.1176922","article-title":"Clinical, imaging, and follow-up observations of patients with anti-GABAB receptor encephalitis","volume":"127","author":"Qiao","year":"2017","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.autrev.2018.08.009_bb0530","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/00207454.2017.1408618","article-title":"The gamma-aminobutyric acid-B receptor (GABAB) encephalitis: clinical manifestations and response to immunotherapy","volume":"128","author":"Cui","year":"2018","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.autrev.2018.08.009_bb0535","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ejpn.2018.01.002","article-title":"Severe GABAA receptor encephalitis without seizures: a paediatric case successfully treated with early immunomodulation","volume":"22","author":"Nikolaus","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.autrev.2018.08.009_bb0540","first-page":"301","article-title":"Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications","volume":"11","author":"De Rosa","year":"2007","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.autrev.2018.08.009_bb0545","first-page":"673","article-title":"Ad Hoc Comittee of the Croatian Society for Neurovascular Disorders, Croatian Medical Association. Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases","volume":"51","author":"Basci\u0107-Kes","year":"2012","journal-title":"Acta Clin Croat"},{"key":"10.1016\/j.autrev.2018.08.009_bb0550","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1212\/NXI.0000000000000207","article-title":"Immunoadsorption therapy in autoimmune encephalitis","volume":"3","author":"Dogan Onugoren","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2018.08.009_bb0555","doi-asserted-by":"crossref","first-page":"107421","DOI":"10.1155\/2014\/107421","article-title":"Biological treatments in Beh\u00e7et's disease: beyond anti-TNF therapy","volume":"2014","author":"Caso","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2018.08.009_bb0560","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/659206","article-title":"Chemokines and chemokine receptors in multiple sclerosis","volume":"2014","author":"Cheng","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2018.08.009_bb0565","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fimmu.2017.00442","article-title":"Hello from the Other Side: how autoantibodies circumvent the blood-brain barrier in autoimmune encephalitis","volume":"8","author":"Platt","year":"2017","journal-title":"Front Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:13:29Z","timestamp":1761599609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218302908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1568997218302908"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.08.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An evolving redefinition of autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}